Published in Transplant Proc on October 01, 1987
Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. Transplantation (1990) 2.59
Pathologic observations in human allograft recipients treated with FK 506. Transplant Proc (1990) 1.80
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg (1994) 1.33
Inhibition by FK506 of established lesions of collagen-induced arthritis in rats. Clin Exp Immunol (1990) 0.89
Effects of a novel immunosuppressive agent, FK506, on human B cell activation. Clin Exp Immunol (1990) 0.83
FK506: the promise and the paradox. Clin Exp Immunol (1991) 0.79
Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience. Clin Transpl (1994) 0.76
In vivo 31P nuclear magnetic resonance findings on heterotopically allografted hearts in rats treated with a novel immunosuppressant, FK506. Heart Vessels (1990) 0.75
Advances in the development of immunosuppressive agents in organ transplantation. Surg Today (1997) 0.75
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet (1979) 6.10
West Nile virus infection in birds and mosquitoes, New York State, 2000. Emerg Infect Dis (2001) 4.27
Improved survival after orthotopic liver grafting. Br Med J (Clin Res Ed) (1981) 3.09
Cyclosporin A in cadaveric organ transplantation. Br Med J (Clin Res Ed) (1981) 2.67
Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A. Lancet (1978) 2.57
Rapamycin for immunosuppression in organ allografting. Lancet (1989) 2.51
West Nile virus in overwintering Culex mosquitoes, New York City, 2000. Emerg Infect Dis (2001) 2.48
The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J Biol Chem (1995) 2.20
Cyclosporine: five years' experience in cadaveric renal transplantation. N Engl J Med (1984) 2.10
West Nile virus isolates from mosquitoes in New York and New Jersey, 1999. Emerg Infect Dis (2001) 2.05
The treatment of systemic lupus erythematosus (SLE) in NZB/W F1 hybrid mice; studies with recombinant murine DNase and with dexamethasone. Clin Exp Immunol (1996) 1.94
Cyclosporin A: preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants. Transplant Proc (1979) 1.94
The generation of transgenic pigs as potential organ donors for humans. Nat Med (1995) 1.86
Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation (2000) 1.83
Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein. Proc Natl Acad Sci U S A (1997) 1.75
A high-resolution NMR probe in which the coil and preamplifier are cooled with liquid helium. 1984. J Magn Reson (2011) 1.75
Cyclosporin A: an immunosuppressive agent preferentially active against proliferating T cells. Transplantation (1979) 1.73
Stomach as source of bacteria colonising respiratory tract during artificial ventilation. Lancet (1978) 1.69
Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejection. Transplantation (1999) 1.67
Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies. QJM (1996) 1.66
Human babesiosis in New York State: an epidemiological description of 136 cases. Clin Infect Dis (1992) 1.61
Kidney transplantation in the dog receiving FK-506. Transplant Proc (1987) 1.54
Umbilicoplasty: the construction of a new umbilicus and correction of umbilical stenosis without external scars. Plast Reconstr Surg (1996) 1.51
Implementation of a proficiency testing program for Lyme disease in New York State. Arch Pathol Lab Med (1994) 1.42
Trends in sexually transmitted infections (other than HIV) in older people: analysis of data from an enhanced surveillance system. Sex Transm Infect (2008) 1.41
Surveillance of sexually transmitted infections in the West Midlands using anonymised individual patient datasets from genitourinary medicine clinics. Commun Dis Public Health (2004) 1.40
Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy. Lancet (1993) 1.40
Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line. Br J Cancer (1987) 1.40
Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J Exp Med (1992) 1.38
Mercuric chloride-treated brown Norway rats develop widespread tissue injury including necrotizing vasculitis. Lab Invest (1992) 1.34
West Nile virus: a case study in how NY State Health Information infrastructure facilitates preparation and response to disease outbreaks. J Public Health Manag Pract (2001) 1.27
Mode of action of cyclosporin A: a new immunosuppressive agent. Transplant Proc (1979) 1.26
Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab Invest (2001) 1.25
Observations about FK-506 in primates. Transplant Proc (1987) 1.25
Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer. Br J Cancer (2000) 1.23
Role of neutrophils in the pathogenesis of experimental vasculitis. Am J Pathol (1996) 1.23
FK-506 in experimental renal allografts. Transplant Proc (1987) 1.23
Autoantibodies to myeloperoxidase in brown Norway rats treated with mercuric chloride. Lab Invest (1992) 1.21
Structure of the bacteriophage lambda Ser/Thr protein phosphatase with sulfate ion bound in two coordination modes. Biochemistry (2000) 1.20
Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation (2000) 1.19
Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells. Am J Pathol (1995) 1.18
Occupational risk of Lyme disease in endemic areas of New York State. Ann N Y Acad Sci (1988) 1.18
Cyclosporin-A in clinical organ grafting. Transplant Proc (1981) 1.16
Lyme disease in New York State: spatial pattern at a regional scale. Am J Trop Med Hyg (2001) 1.14
Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir. J Antimicrob Chemother (2001) 1.14
Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men. AIDS (2000) 1.14
Clinical pharmacology and safety evaluation of Timentin. Am J Med (1985) 1.12
Interleukin-4 gene expression in mercury-induced autoimmunity. Scand J Immunol (1995) 1.11
Serosurvey for human babesiosis in New York. J Infect Dis (1980) 1.10
Lymphoma in renal allograft patients treated with cyclosporin-A as one of the immunosuppressive agents. Transplant Proc (1981) 1.08
Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation (2000) 1.07
Three-month survival of HDAFF transgenic pig hearts transplanted into primates. Transplant Proc (1999) 1.06
Poor penetration of the male genital tract by HIV-1 protease inhibitors. AIDS (1999) 1.05
Inflammatory polyarthritis induced by mercuric chloride in the Brown Norway rat. Lab Invest (1995) 1.05
Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States. Am J Med (1999) 1.04
Physiological aspects of pig-to-primate renal xenotransplantation. Kidney Int (2001) 1.03
Reactivity of fluoride dentifrices with artificial caries. I. Effects on early lesions: F uptake, surface hardening and remineralization. Caries Res (1987) 1.02
The use of Cyclosporin A immunosuppression in organ grafting. Immunol Rev (1982) 1.02
Characterization of pigs transgenic for human decay-accelerating factor. Transplantation (1997) 1.01
Prolonged survival of hamster to rat heart xenografts with cyclophosphamide therapy. Transplant Proc (1992) 1.01
Overexpression of cardiac I-kappaBalpha prevents endotoxin-induced myocardial dysfunction. Am J Physiol Heart Circ Physiol (2001) 1.01
Regulatory role of OX22high T cells in mercury-induced autoimmunity in the brown Norway rat. J Exp Med (1993) 1.01
Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation (1998) 0.99
Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation (1998) 0.99
Evidence that long-term survival of concordant xenografts is achieved by inhibition of antispecies antibody production. Transplantation (1992) 0.98
A method to study sustained antimicrobial activity of rinse and dentifrice components on biofilm viability in vivo. J Clin Periodontol (2006) 0.98
A longitudinal microhardness analysis of fluoride dentifrice effects on lesion progression in vitro. Caries Res (1987) 0.97
Early renal allograft rejection episodes are less aggressive with cyclosporin-A immunosuppression. Transplant Proc (1983) 0.96
Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation (1997) 0.96
Penetration of efavirenz into the male genital tract: drug concentrations and antiviral activity in semen and blood of HIV-1-infected men. AIDS (2001) 0.96
Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus. Diabet Med (1999) 0.95
Delayed allograft rejection in primates treated with anti-IL-2 receptor monoclonal antibody Campath-6. Transplantation (1988) 0.95
Cyclosporin A. Clinical pharmacology and therapeutic potential. Drugs (1982) 0.94
Both concordant and discordant heart xenografts are rejected by athymic (nude) rats with the same tempo as in T cell competent animals. Transplant Proc (1991) 0.94
The immune status of transplant recipients immunosuppressed with cyclosporin-A. Transplant Proc (1981) 0.94
An analysis of concordant xenograft rejection in the nude rat model. Transplant Proc (1990) 0.94
Consistent prolonged "concordant" survival of hamster-to-rat cardiac xenografts by inhibition of anti-species antibodies with methotrexate. Transplant Proc (1993) 0.93
Regulation of the complement cascade by soluble complement receptor type 1. Protective effect in experimental liver ischemia and reperfusion. Transplantation (1995) 0.93
The use of cyclosporin A in clinical organ grafting. Ann Surg (1982) 0.93
Hydrogen peroxide-induced endothelial retraction is accompanied by a loss of the normal spatial organization of endothelial cell adhesion molecules. Am J Pathol (1995) 0.93
Cyclosporin A exacerbates mercuric chloride-induced vasculitis in the brown Norway rat. Lab Invest (1995) 0.93
Babesiosis in Long Island. Host-parasite relationships of rodent- and human-derived Babesia microti isolates in hamsters. Am J Trop Med Hyg (1978) 0.92
Evidence for multiple foci of eastern equine encephalitis virus (Togaviridae:Alphavirus) in central New York State. J Med Entomol (1996) 0.92
Antioxidant vitamin therapy alters burn trauma-mediated cardiac NF-kappaB activation and cardiomyocyte cytokine secretion. J Trauma (2001) 0.91
New distribution records of Amblyomma americanum (L.) (Acari: Ixodidae) in New York State. J Vector Ecol (1997) 0.91
Progress in xenotransplantation. Clin Nephrol (2000) 0.91
Role of p38 mitogen-activated protein kinase in cardiac myocyte secretion of the inflammatory cytokine TNF-alpha. Am J Physiol Heart Circ Physiol (2001) 0.91
The effect of long-term cyclosporin A on renal function. Lancet (1981) 0.91
Changing patterns in the incidence of Rocky Mountain Spotted Fever on Long Island (1971-1976). Am J Epidemiol (1977) 0.90